Cargando…

SARS‐CoV‐2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?

Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters δ and κ, is a recently described SARS‐CoV‐2 variant under investigation first identified in October 2020 in India. As of May 2021, three sublineages labeled as B.1.617.1 (κ), B.1.617.2 (δ), and B.1.617.3 have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pascarella, Stefano, Ciccozzi, Massimo, Zella, Davide, Bianchi, Martina, Benedetti, Francesca, Benvenuto, Domenico, Broccolo, Francesco, Cauda, Roberto, Caruso, Arnaldo, Angeletti, Silvia, Giovanetti, Marta, Cassone, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426736/ https://www.ncbi.nlm.nih.gov/pubmed/34260088 http://dx.doi.org/10.1002/jmv.27210

Ejemplares similares

The value of electrostatic potentials of the spike receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 variants of concern
por: Pascarella, Stefano, et al.
Publicado: (2022)

Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
por: Benvenuto, Domenico, et al.
Publicado: (2020)

Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages
por: Pascarella, Stefano, et al.
Publicado: (2023)

Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant
por: Pascarella, Stefano, et al.
Publicado: (2021)

The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants
por: Pascarella, Stefano, et al.
Publicado: (2022)

Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
por: Bianchi, Martina, et al.
Publicado: (2020)

Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
por: Giovanetti, Marta, et al.
Publicado: (2021)

Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion
por: Scarpa, Fabio, et al.
Publicado: (2022)

Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage
por: Scarpa, Fabio, et al.
Publicado: (2023)

Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1
por: Benedetti, Francesca, et al.
Publicado: (2020)

The variants question: What is the problem?
por: Zella, Davide, et al.
Publicado: (2021)

Application of the ARIMA model on the COVID-2019 epidemic dataset
por: Benvenuto, Domenico, et al.
Publicado: (2020)

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
por: Liu, Chang, et al.
Publicado: (2021)

Candidate Multi-Epitope Vaccine against Corona B.1.617 Lineage: In Silico Approach
por: Seadawy, Mohamed G., et al.
Publicado: (2022)

Update on the Phylodynamic and Genetic Variability of Marburg Virus
por: Scarpa, Fabio, et al.
Publicado: (2023)

Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617
por: Fan, Lin-qian, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5
por: Scarpa, Fabio, et al.
Publicado: (2023)

Probing the Increased Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 (Indian Variant) From Predicted Spike Protein Structure
por: Hajj-Hassan, Houssein, et al.
Publicado: (2021)

SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy
por: Giovanetti, Marta, et al.
Publicado: (2021)

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
por: Edara, Venkata-Viswanadh, et al.
Publicado: (2021)

Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach
por: Ranjan, Prashant, et al.
Publicado: (2022)

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
por: Augusto, Gilles, et al.
Publicado: (2021)

The surgions mate, 1617
Publicado: (1979)

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
por: Hoffmann, Markus, et al.
Publicado: (2021)

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
por: Peng, Lei, et al.
Publicado: (2021)

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
por: Peng, Lei, et al.
Publicado: (2022)

Variant-specific RT-qPCR for rapid screening of B.1.617 mutations in SARS-CoV-2
por: Jallul, Mwada, et al.
Publicado: (2022)

Monitoring Monkeypox: Safeguarding Global Health through Rapid Response and Global Surveillance
por: Giovanetti, Marta, et al.
Publicado: (2023)

The global spread of 2019-nCoV: a molecular evolutionary analysis
por: Benvenuto, Domenico, et al.
Publicado: (2020)

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
por: Ferreira, Isabella A T M, et al.
Publicado: (2021)

Characterization of mutations modulating enhanced transmissibility of SARS-CoV-2 B.1.617+ (Delta) variant using In Silico tools
por: Shahhosseini, Nariman
Publicado: (2022)

The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera
por: Li, Gen, et al.
Publicado: (2021)

Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America
por: Pachetti, Maria, et al.
Publicado: (2020)

Gut Microbiota and COVID-19: Potential Implications for Disease Severity
por: Rocchi, Giulia, et al.
Publicado: (2022)

Joining Forces against Antibiotic Resistance: The One Health Solution
por: Cella, Eleonora, et al.
Publicado: (2023)

Emerging Variants of B.1.617 Lineage Identified Among Returning Chinese Employees Working in India — Chongqing Municipality, China, April 2021
por: Ye, Sheng, et al.
Publicado: (2021)

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
por: Zhang, Li, et al.
Publicado: (2022)

Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy
por: Angeletti, Silvia, et al.
Publicado: (2022)

The first Italian outbreak of SARS‐CoV‐2 B.1.1.7 lineage in Corzano, Lombardy
por: Messali, Serena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibpbco8185i44dnr3cudat8od6